EUVIMEDEUVIMED entdecken
Crossref

Three-Year Outcomes Following Mitral Valve-in-Ring and Valve-in-Valve Procedures

Daniel Maldonado Gaekel, Lara Waldschmidt, Sebastian Ludwig, Daniel Kalbacher, Johannes Schirmer, Stefan Blankenberg, Hermann Reichenspurner, Niklas Schofer, Andreas Schaefer

The Thoracic and Cardiovascular Surgeon · 01.06.2026 · 74 (04) · 332-340

DOI: 10.1055/a-2679-5606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.06.2026. Verfasst von Daniel Maldonado Gaekel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, University Medical Center Hamburg-Eppendorf University Heart and Vascular Center, Hamburg, Hamburg, Germany. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Mitral Valve, Transcatheter Mitral Valve Replacement, Mitral Valve Insufficiency. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients at elevated risk for redo mitral valve surgery, transcatheter mitral valve replacement (TMVR) can be taken into consideration as a less invasive alternative. However, long-term outcome data on mitral valve-in-ring (ViR) and valve-in-valve (ViV) procedures are scarce. We herein report the 3-year outcomes following these interventions. Between 2014 and 2023, 51 consecutive patients received ViR/ViV TMVR at our center. Baseline, periprocedural, and 3-year outcome parameters were analyzed according to M-VARC criteria. Among 51 patients (70.9 ± 13.6 years, Society of Thoracic Surgeons (STS) score 3.3 ± 2.3%, left ventricular ejection fraction (LVEF) 50 ± 12%), 19 underwent ViR and 32 underwent ViV TMVR. Follow-up ranged from 1 to 71 months. The 30-day mortality rate was 5.9% (3/51 patients). Over time, access shifted from transapical to transseptal (p for trend

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve ProsthesisMitral ValveTranscatheter Mitral Valve ReplacementMitral Valve InsufficiencyMitral Valve AnnuloplastyHeart Valve Prosthesis ImplantationHumansTreatment OutcomeTime FactorsFemaleRisk FactorsAgedProsthesis DesignMaleAged, 80 and overMiddle AgedPostoperative ComplicationsRetrospective StudiesRecovery of FunctionReoperationRisk Assessment

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, University Medical Center Hamburg-Eppendorf University Heart and Vascular Center, Hamburg, Hamburg, Germany.
  • Department of Cardiology, University Medical Center Hamburg-Eppendorf University Heart and Vascular Center, Hamburg, Hamburg, Germany.

Zitieren

APA

Gaekel, D. M., Waldschmidt, L., Ludwig, S., Kalbacher, D., Schirmer, J., Blankenberg, S., Reichenspurner, H., Schofer, N., & Schaefer, A. (2026). Three-Year Outcomes Following Mitral Valve-in-Ring and Valve-in-Valve Procedures. The Thoracic and Cardiovascular Surgeon, 74(04), 332-340. https://doi.org/10.1055/a-2679-5606

Vancouver

Gaekel DM, Waldschmidt L, Ludwig S, Kalbacher D, Schirmer J, Blankenberg S, et al. Three-Year Outcomes Following Mitral Valve-in-Ring and Valve-in-Valve Procedures. The Thoracic and Cardiovascular Surgeon. 2026;74(04):332-340. doi:10.1055/a-2679-5606

BibTeX
@article{Gaekel2026,
  author = {Gaekel, Daniel Maldonado and Waldschmidt, Lara and Ludwig, Sebastian and Kalbacher, Daniel and Schirmer, Johannes and Blankenberg, Stefan and Reichenspurner, Hermann and Schofer, Niklas and Schaefer, Andreas},
  title = {Three-Year Outcomes Following Mitral Valve-in-Ring and Valve-in-Valve Procedures},
  journal = {The Thoracic and Cardiovascular Surgeon},
  year = {2026},
  volume = {74},
  number = {04},
  pages = {332--340},
  doi = {10.1055/a-2679-5606}
}
Kostenlos starten →